Imiquimod (IMQ)-induced elevated TL1A expression at lesions in psoriasis-like mice, and elevated TL1A exacerbated the psoriasis phenotype through increasing the number of T cells, neutrophils, and DCs, and upregulating inflammatory cytokines IL-17 and IFN-γ. Here, IL17A is linked to psoriasis.